Wendy Thomson

Wendy Thomson

Auto-generated profile, based on publicly available information

Wendy Thomson

Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2010 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BCBIRAC Consortium
BIRAC Consortium
ESEli A Stahl
Eli A Stahl
YCYEAR Consortium
YEAR Consortium
SRSoumya Raychaudhuri
Soumya Raychaudhuri
ERElaine F Remmers
Elaine F Remmers
RPRobert M Plenge
Robert M Plenge

1 April 2010 in Nature
Verified
Journal Article
Open access
PDF file
WCWellcome Trust Case Control Consortium
Wellcome Trust Case Control Consortium
NCNick Craddock
Nick Craddock
MHMatthew E Hurles
Matthew E Hurles
NCNiall Cardin
Niall Cardin
RPRichard D Pearson
Richard D Pearson
PDPeter Donnelly
Peter Donnelly
Copy number variants (CNVs) account for a major proportion of human genetic polymorphism and have been predicted to have an important role in genetic susceptibility to common disease. To address this we undertook a large, direct genome-wide study of association between CNVs and eight common human diseases. Using a purpose-designed array we typed ∼19,000 individuals into distinct copy-number classes at 3,432 polymorphic CNVs, including an estimated ∼50% of all common CNVs larger than 500 base pairs. We identified several biological artefacts that lead to false-positive associations, including systematic CNV differences between DNAs derived from blood and cell lines. Association testing and follow-up replication analyses confirmed three loci where CNVs were associated with disease—IRGM for Crohn’s disease, HLA for Crohn’s disease, rheumatoid arthritis and type 1 diabetes, and TSPAN8 for type 2 diabetes—although in each case the locus had previously been identified in single nucleotide polymorphism (SNP)-based studies, reflecting our observation that most common CNVs that are well-typed on our array are well tagged by SNPs and so have been indirectly explored through SNP studies. We conclude that common CNVs that can be typed on existing platforms are unlikely to contribute greatly to the genetic basis of common human diseases.

25 April 2010 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TCThe Wellcome Trust Case Control Consortium
The Wellcome Trust Case Control Consortium
JLJason Z Liu
Jason Z Liu
FTFederica Tozzi
Federica Tozzi
DWDawn M Waterworth
Dawn M Waterworth
SPSreekumar G Pillai
Sreekumar G Pillai
JMJonathan Marchini
Jonathan Marchini

1 October 1993 in Rheumatology
Verified
Journal Article
Closed access
PDF file
ASA. J. Silman
A. J. Silman
AMA. J. Macgregor
A. J. Macgregor
WTW. Thomson
W. Thomson
SHS. Holligan
S. Holligan
DCD. Carthy
D. Carthy
WOW. E. R. Ollier
W. E. R. Ollier
We report the concordance rate for RA in a nationwide study of 91 monozygotic (MZ) and 112 dizygotic (DZ) pairs. Twin pairs were recruited from both a national media campaign and a 2-month prospective inquiry of all UK rheumatologists. Disease status was established following a structured clinical and serological appraisal, together with radiological assesment where necessary. Zygosity was confirmed using DNA fingerprinting. In all, 14 (15.4%) of the MZ and four (3.6%) of the DZ pairs were disease concordant (risk ratio: 4.3 95% CI 1.5 to 12.6). There was no difference in the concordance between the media and clinical derived twins. Further the excess MZ concordance persisted after adjusting for age, age at disease onset, sex and rheumatoid factor status. Analysing the data in relation to the timing of disease onset in the first affected twin showed that subsequent disease risk in the initially unaffected co-twins of the MZ affected probands increased with increasing duration of follow-up. We conclude that the overall MZ concordance at 15% is lower than the 30% figure normally quoted from a study some 30 years ago and sets a ceiling at the potential genetic contribution to disease susceptibility.

21 April 2013 in Nature Genetics
Verified
Journal Article
Open access
PDF file
BRBoston Children'S Jia Registry
Boston Children'S Jia Registry
AHAnne Hinks
Anne Hinks
BGBritish Society of Paediatric and Adolescent Rheumatology (BSPAR) Study Group
British Society of Paediatric and Adolescent Rheumatology (BSPAR) Study Group
C(Childhood Arthritis Prospective Study (CAPS)
Childhood Arthritis Prospective Study (CAPS)
C(Childhood Arthritis Response to Medication Study (CHARMS)
Childhood Arthritis Response to Medication Study (CHARMS)
STSusan D Thompson
Susan D Thompson
Anne Hinks and colleagues identify 14 new susceptibility loci for juvenile idiopathic arthritis through targeted analyses of genomic regions implicated in immune function. Their study implicates several pathways, including IL-2 signaling, in the pathogenesis of this common childhood autoimmune disease. We used the Immunochip array to analyze 2,816 individuals with juvenile idiopathic arthritis (JIA), comprising the most common subtypes (oligoarticular and rheumatoid factor–negative polyarticular JIA), and 13,056 controls. We confirmed association of 3 known JIA risk loci (the human leukocyte antigen (HLA) region, PTPN22 and PTPN2) and identified 14 loci reaching genome-wide significance (P < 5 × 10−8) for the first time. Eleven additional new regions showed suggestive evidence of association with JIA (P < 1 × 10−6). Dense mapping of loci along with bioinformatics analysis refined the associations to one gene in each of eight regions, highlighting crucial pathways, including the interleukin (IL)-2 pathway, in JIA disease pathogenesis. The entire Immunochip content, the HLA region and the top 27 loci (P < 1 × 10−6) explain an estimated 18, 13 and 6% of the risk of JIA, respectively. In summary, this is the largest collection of JIA cases investigated so far and provides new insight into the genetic basis of this childhood autoimmune disease.

4 November 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
WCWellcome Trust Case Control Consortium
Wellcome Trust Case Control Consortium
WTWendy Thomson
Wendy Thomson
YCYEAR Consortium
YEAR Consortium
ABAnne Barton
Anne Barton
XKXiayi Ke
Xiayi Ke
JWJane Worthington
Jane Worthington